108 results on '"Silbert, BS"'
Search Results
2. Incidence of Cognitive Decline 5 Years after Orthopaedic Surgery According to Method of Assessment
- Author
-
Atkins, KJ, Evered, LA, Scott, DA, Silbert, BS, Atkins, KJ, Evered, LA, Scott, DA, and Silbert, BS
- Abstract
Background Older adults who undergo elective surgery may be at risk of an altered cognitive trajectory leading to long‐term decline. We investigated the incidence of cognitive decline in the elderly following elective non‐cardiac surgery five years post‐operatively and examined whether differences in classification criteria for cognitive outcomes resulted in different incidence rates. Method We prospectively studied older adults following orthopaedic surgery, alongside non‐surgical control participants. All participants completed a battery of neuropsychological tests before surgery and again five years postoperatively. We classified Postoperative Cognitive Dysfunction (POCD), (a change‐based construct historically used in anesthesiology and surgery) as a decline of two standard deviations (SD) on two or more cognitive tests compared to controls. We also assessed Neurocognitive Disorders (NCD) relative to change in controls, a term recently introduced to align cognitive disorders with community medicine. Major NCD was defined by a decline of two SD on any test, accompanied by a subjective memory complaint and observed decline in instrumental activities of daily living. Mild NCD was classified as a memory complaint and a decline of one SD on at least one test. Result From an initial 300 participants enrolled, 227 participants (surgical = 199, non‐surgical control = 34) completed the five year follow‐up. Average (SD) follow‐up age was 74.8 (6. 6) years and 154 (67.8%) were female. We identified POCD at five years in 28 (14.2%), and major NCD in 38 (19.3%) participants. Mild NCD was more common, occurring in 81 (41.1%) participants. Cognitive decline five years postoperatively was associated with increasing age, whereas education history and anesthetic technique (spinal or GA) were not significantly associated. Further analyses will determine the role of cardiovascular risk factors. Conclusion We found both overlap and differences in the incidence rate of cognitive decl
- Published
- 2022
3. Cognitive Function Before and After Left Heart Catheterization
- Author
-
Scott, DA, Evered, L, Maruff, P, MacIsaac, A, Maher, S, Silbert, BS, Scott, DA, Evered, L, Maruff, P, MacIsaac, A, Maher, S, and Silbert, BS
- Abstract
BACKGROUND: Hospital procedures have been associated with cognitive change in older patients. This study aimed to document the prevalence of mild cognitive impairment in individuals undergoing left heart catheterization (LHC) before the procedure and the incidence of cognitive decline to 3 months afterwards. METHODS AND RESULTS: We conducted a prospective, observational, clinical investigation of elderly participants undergoing elective LHC. Cognition was assessed using a battery of written tests and a computerized cognitive battery before the LHC and then at 3 months afterwards. The computerized tests were also administered at 24 hours (or discharge) and 7 days after LHC. A control group of 51 community participants was recruited to calculate cognitive decline using the Reliable Change Index. Of 437 participants, mild cognitive impairment was identified in 226 (51.7%) before the procedure. Computerized tests detected an incidence of cognitive decline of 10.0% at 24 hours and 7.5% at 7 days. At 3 months, written tests detected an incidence of cognitive decline of 13.1% and computerized tests detected an incidence of 8.5%. Cognitive decline at 3 months using written tests was associated with increasing age, whereas computerized tests showed cognitive decline was associated with baseline amnestic mild cognitive impairment, diabetes mellitus, and prior coronary stenting. CONCLUSIONS: More than half the patients aged >60 years presenting for LHC have mild cognitive impairment. LHC is followed by cognitive decline in 8% to 13% of individuals at 3 months after the procedure. Subtle cognitive decline both before and after LHC is common and may have important clinical implications. CLINICAL TRIAL REGISTRATION INFORMATION: URL: www.anzctr.org.au. Unique identifier: ACTRN12607000051448.
- Published
- 2018
4. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
- Author
-
Myles, PS, Painter, T, Silbert, BS, McGuinness, S, Byrne, K, Chan, MTV, Smith, Julian A, Forbes, Andrew, Jayarajah, Mohandas, Cooper, D James, Marasco, Silvana, McNeil, John, Bussières, Jean S, Landoni, Giovanni, Wallace, Sophie, Myles, PS, Painter, T, Silbert, BS, McGuinness, S, Byrne, K, Chan, MTV, Smith, Julian A, Forbes, Andrew, Jayarajah, Mohandas, Cooper, D James, Marasco, Silvana, McNeil, John, Bussières, Jean S, Landoni, Giovanni, and Wallace, Sophie
- Abstract
Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes. Furthermore, there are concerns that tranexamic acid may have prothrombotic and proconvulsant effects. In a trial with a 2-by-2 factorial design, we randomly assigned patients who were scheduled to undergo coronary-artery surgery and were at risk for perioperative complications to receive aspirin or placebo and tranexamic acid or placebo. The results of the tranexamic acid comparison are reported here. The primary outcome was a composite of death and thrombotic complications (nonfatal myocardial infarction, stroke, pulmonary embolism, renal failure, or bowel infarction) within 30 days after surgery. Of the 4662 patients who were enrolled and provided consent, 4631 underwent surgery and had available outcomes data; 2311 were assigned to the tranexamic acid group and 2320 to the placebo group. A primary outcome event occurred in 386 patients (16.7%) in the tranexamic acid group and in 420 patients (18.1%) in the placebo group (relative risk, 0.92; 95% confidence interval, 0.81 to 1.05; P=0.22). The total number of units of blood products that were transfused during hospitalization was 4331 in the tranexamic acid group and 7994 in the placebo group (P<0.001). Major hemorrhage or cardiac tamponade leading to reoperation occurred in 1.4% of the patients in the tranexamic acid group and in 2.8% of the patients in the placebo group (P=0.001), and seizures occurred in 0.7% and 0.1%, respectively (P=0.002 by Fisher's exact test). Among patients undergoing coronary-artery surgery, tranexamic acid was associated with a lower risk of bleeding than was placebo, without a higher risk of death or thrombotic complications within 30 days after surgery. Tranexamic acid was associated with a higher risk of postoperative seizures. (Funded by the Australian National Health and Medical Research Council and others; ATACAS Australia New Zealand
- Published
- 2017
5. Stopping vs. Continuing Aspirin before Coronary Artery Surgery
- Author
-
ANZCA Clinical Trials Network, Myles, PS, Painter, TW, Silbert, BS, Smith, JA, Forbes, A, Silbert, B, Jayarajah, M, Painter, T, Cooper, DJ, Marasco, S, McNeil, J, Bussières, JS, Wallace, S, ATACAS Investigators of the ANZCA Clinical Trials Network, ANZCA Clinical Trials Network, Myles, PS, Painter, TW, Silbert, BS, Smith, JA, Forbes, A, Silbert, B, Jayarajah, M, Painter, T, Cooper, DJ, Marasco, S, McNeil, J, Bussières, JS, Wallace, S, and ATACAS Investigators of the ANZCA Clinical Trials Network
- Abstract
BACKGROUND: Most patients with coronary artery disease receive aspirin for primary or secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of bleeding in patients undergoing surgery, but it is unclear whether aspirin should be stopped before coronary artery surgery. METHODS: We used a 2-by-2 factorial trial design to randomly assign patients who were scheduled to undergo coronary artery surgery and were at risk for perioperative complications to receive aspirin or placebo and tranexamic acid or placebo. The results of the aspirin trial are reported here. Patients were randomly assigned to receive 100 mg of aspirin or matched placebo preoperatively. The primary outcome was a composite of death and thrombotic complications (nonfatal myocardial infarction, stroke, pulmonary embolism, renal failure, or bowel infarction) within 30 days after surgery. RESULTS: Among 5784 eligible patients, 2100 were enrolled; 1047 were randomly assigned to receive aspirin and 1053 to receive placebo. A primary outcome event occurred in 202 patients in the aspirin group (19.3%) and in 215 patients in the placebo group (20.4%) (relative risk, 0.94; 95% confidence interval, 0.80 to 1.12; P=0.55). Major hemorrhage leading to reoperation occurred in 1.8% of patients in the aspirin group and in 2.1% of patients in the placebo group (P=0.75), and cardiac tamponade occurred at rates of 1.1% and 0.4%, respectively (P=0.08). CONCLUSIONS: Among patients undergoing coronary artery surgery, the administration of preoperative aspirin resulted in neither a lower risk of death or thrombotic complications nor a higher risk of bleeding than that with placebo. (Funded by the Australian National Health and Medical Research Council and others; Australia New Zealand Clinical Trials Registry number, ACTRN12605000557639.).
- Published
- 2016
6. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
- Author
-
Collins, S, Silbert, BS, Li, QX, Villmagne, VL, Doecke, JD, Rembach, A, Sarros, S, Varghese, S, McGlade, A, Laughton, KM, Pertile, KK, Fowler, CJ, Rumble, RL, Trounson, BO, Taddei, K, Rainey-Smith, SR, Laws, SM, Robertson, JS, Evered, LA, Silbert, B, Ellis, KA, Rowe, CC, Macaulay, SL, Darby, D, Martins, RN, Ames, D, Masters, CL, AIBL Research Group, Collins, S, Silbert, BS, Li, QX, Villmagne, VL, Doecke, JD, Rembach, A, Sarros, S, Varghese, S, McGlade, A, Laughton, KM, Pertile, KK, Fowler, CJ, Rumble, RL, Trounson, BO, Taddei, K, Rainey-Smith, SR, Laws, SM, Robertson, JS, Evered, LA, Silbert, B, Ellis, KA, Rowe, CC, Macaulay, SL, Darby, D, Martins, RN, Ames, D, Masters, CL, and AIBL Research Group
- Abstract
BACKGROUND: The cerebrospinal fluid (CSF) amyloid-β (Aβ)(1-42), total-tau (T-tau), and phosphorylated-tau (P-tau181P) profile has been established as a valuable biomarker for Alzheimer's disease (AD). OBJECTIVE: The current study aimed to determine CSF biomarker cut-points using positron emission tomography (PET) Aβ imaging screened subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, as well as correlate CSF analyte cut-points across a range of PET Aβ amyloid ligands. METHODS: Aβ pathology was determined by PET imaging, utilizing ¹¹C-Pittsburgh Compound B, ¹⁸F-flutemetamol, or ¹⁸F-florbetapir, in 157 AIBL participants who also underwent CSF collection. Using an INNOTEST assay, cut-points were established (Aβ(1-42) >544 ng/L, T-tau <407 ng/L, and P-tau181P <78 ng/L) employing a rank based method to define a "positive" CSF in the sub-cohort of amyloid-PET negative healthy participants (n = 97), and compared with the presence of PET demonstrated AD pathology. RESULTS: CSF Aβ(1-42) was the strongest individual biomarker, detecting cognitively impaired PET positive mild cognitive impairment (MCI)/AD with 85% sensitivity and 91% specificity. The ratio of P-tau181P or T-tau to Aβ(1-42) provided greater accuracy, predicting MCI/AD with Aβ pathology with ≥92% sensitivity and specificity. Cross-validated accuracy, using all three biomarkers or the ratio of P-tau or T-tau to Aβ(1-42) to predict MCI/AD, reached ≥92% sensitivity and specificity. CONCLUSIONS: CSF Aβ(1-42) levels and analyte combination ratios demonstrated very high correlation with PET Aβ imaging. Our study offers additional support for CSF biomarkers in the early and accurate detection of AD pathology, including enrichment of patient cohorts for treatment trials even at the pre-symptomatic stage.
- Published
- 2015
7. The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
- Author
-
ANZCA Clinical Trials Network, Chan, MTV, Myles, PS, Paech, MJ, Silbert, BS, Leslie, K, Forbes, A, Peyton, PJ, Beattie, S, Sessler, DI, Devereaux, PJ, Schricker, T, Wallace, S, ANZCA Trials Group for the ENIGMA-II investigators, ANZCA Clinical Trials Network, Chan, MTV, Myles, PS, Paech, MJ, Silbert, BS, Leslie, K, Forbes, A, Peyton, PJ, Beattie, S, Sessler, DI, Devereaux, PJ, Schricker, T, Wallace, S, and ANZCA Trials Group for the ENIGMA-II investigators
- Abstract
BACKGROUND: Nitrous oxide is commonly used in general anaesthesia but concerns exist that it might increase perioperative cardiovascular risk. We aimed to gather evidence to establish whether nitrous oxide affects perioperative cardiovascular risk. METHODS: We did an international, randomised, assessor-blinded trial in patients aged at least 45 years with known or suspected coronary artery disease having major non-cardiac surgery. Patients were randomly assigned via automated telephone service, stratified by site, to receive a general anaesthetic with or without nitrous oxide. Attending anaesthetists were aware of patients' group assignments, but patients and assessors were not. The primary outcome measure was a composite of death and cardiovascular complications (non-fatal myocardial infarction, stroke, pulmonary embolism, or cardiac arrest) within 30 days of surgery. Our modified intention-to-treat population included all patients randomly assigned to groups and undergoing induction of general anaesthesia for surgery. This trial is registered at ClinicalTrials.gov, number NCT00430989. FINDINGS: Of 10,102 eligible patients, we enrolled 7112 patients between May 30, 2008, and Sept 28, 2013. 3543 were assigned to receive nitrous oxide and 3569 were assigned not to receive nitrous oxide. 3483 patients receiving nitrous oxide and 3509 not receiving nitrous oxide were assessed for the primary outcome. The primary outcome occurred in 283 (8%) patients receiving nitrous oxide and in 296 (8%) patients not receiving nitrous oxide (relative risk 0·96, 95% CI 0·83–1·12; p=0·64). Surgical site infection occurred in 321 (9%) patients assigned to nitrous oxide, and in 311 (9%) patients in the no-nitrous oxide group (p=0·61), and severe nausea and vomiting occurred in 506 patients (15%) assigned to nitrous oxide and 378 patients (11%) not assigned to nitrous oxide (p<0·0001). INTERPRETATION: Our findings support the safety profile of nitrous oxide use in major non-cardiac surgery
- Published
- 2014
8. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.
- Author
-
Chan, MTV, Leslie, K, Myles, PS, Paech, MJ, Peyton, PJ, Silbert, BS, Forbes, A, Williamson, E, Chan, MTV, Leslie, K, Myles, PS, Paech, MJ, Peyton, PJ, Silbert, BS, Forbes, A, and Williamson, E
- Abstract
BACKGROUND: There is a plausible pathophysiologic rationale for increased long-term cardiovascular morbidity and mortality in patients receiving significant exposure to nitrous oxide. However, this relationship has not been established clinically. The ENIGMA trial randomized 2050 patients having noncardiac surgery lasting more than 2 hours to nitrous oxide-based or nitrous oxide-free anesthesia. We conducted a follow-up study of the ENIGMA patients to evaluate the risk of cardiovascular events in the longer term. METHODS: The trial case report forms and medical records of all study patients were reviewed. The date and cause of death and occurrence of myocardial infarction or stroke were recorded. A telephone interview was then conducted with all surviving patients. The primary endpoint of the study was survival. RESULTS: The median follow-up time was 3.5 (range: 0 to 5.7) years. Three hundred eighty patients (19%) had died since the index surgery, 91 (4.5%) were recorded as having myocardial infarction, and 44 (2.2%) had a stroke during the entire follow-up period. Nitrous oxide did not significantly increase the risk of death [hazard ratio = 0.98 (95% confidence interval, CI: 0.80 to 1.20; P = 0.82)]. The adjusted odds ratio for myocardial infarction in patients administered nitrous oxide was 1.59 (95% CI: 1.01 to 2.51; P = 0.04) and for stroke was 1.01 (95% CI: 0.55 to 1.87; P = 0.97). CONCLUSIONS: The administration of nitrous oxide was associated with increased long-term risk of myocardial infarction, but not of death or stroke in patients enrolled in the ENIGMA trial. The exact relationship between nitrous oxide administration and serious long-term adverse outcomes will require confirmation by an appropriately designed large randomized controlled trial.
- Published
- 2011
9. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial.
- Author
-
ANZCA Clinical Trials Network, Myles, PS, Peyton, PJ, Silbert, BS, Rigg, J, Hunt, J, Rigg, JR, Sessler, DI, ANZCA Clinical Trials Network, Myles, PS, Peyton, PJ, Silbert, BS, Rigg, J, Hunt, J, Rigg, JR, and Sessler, DI
- Abstract
Objective To compare long term recurrence of cancer and survival of patients having major abdominal surgery for cancer. Design Long term follow-up of prospective randomised controlled clinical trial in which patients were randomly assigned to receive general anaesthesia with or without epidural block for at least three postoperative days. Setting 23 hospitals in Australia, New Zealand, and Asia. Participants 503 adult patients who had potentially curative surgery for cancer. Main outcome measure Cancer-free survival (analysis was by intention to treat). Results Long term follow-up data were available for 94% (n=446) of eligible participants. The median time to recurrence of cancer or death was 2.8 (95% confidence interval 0.7 to 8.7) years in the control group and 2.6 (0.7 to 8.7) years in the epidural group (P=0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% confidence interval 0.76 to 1.17; P=0.61). Conclusion Use of epidural block in abdominal surgery for cancer is not associated with improved cancer-free survival. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12607000637448
- Published
- 2011
10. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.
- Author
-
Leslie, K, Myles, PS, Chan, MTV, Paech, MJ, Peyton, P, Silbert, BS, Forbes, Andrew, Williamson, Elizabeth, Leslie, K, Myles, PS, Chan, MTV, Paech, MJ, Peyton, P, Silbert, BS, Forbes, Andrew, and Williamson, Elizabeth
- Abstract
There is a plausible pathophysiologic rationale for increased long-term cardiovascular morbidity and mortality in patients receiving significant exposure to nitrous oxide. However, this relationship has not been established clinically. The ENIGMA trial randomized 2050 patients having noncardiac surgery lasting more than 2 hours to nitrous oxide-based or nitrous oxide-free anesthesia. We conducted a follow-up study of the ENIGMA patients to evaluate the risk of cardiovascular events in the longer term. The trial case report forms and medical records of all study patients were reviewed. The date and cause of death and occurrence of myocardial infarction or stroke were recorded. A telephone interview was then conducted with all surviving patients. The primary endpoint of the study was survival. The median follow-up time was 3.5 (range: 0 to 5.7) years. Three hundred eighty patients (19%) had died since the index surgery, 91 (4.5%) were recorded as having myocardial infarction, and 44 (2.2%) had a stroke during the entire follow-up period. Nitrous oxide did not significantly increase the risk of death [hazard ratio = 0.98 (95% confidence interval, CI: 0.80 to 1.20; P = 0.82)]. The adjusted odds ratio for myocardial infarction in patients administered nitrous oxide was 1.59 (95% CI: 1.01 to 2.51; P = 0.04) and for stroke was 1.01 (95% CI: 0.55 to 1.87; P = 0.97). The administration of nitrous oxide was associated with increased long-term risk of myocardial infarction, but not of death or stroke in patients enrolled in the ENIGMA trial. The exact relationship between nitrous oxide administration and serious long-term adverse outcomes will require confirmation by an appropriately designed large randomized controlled trial.
- Published
- 2011
11. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design.
- Author
-
Myles, PS, Silbert, BS, Smith, J, Knight, J, Cooper, DJ, McNeil, J, Esmore, DS, Buxton, B, Krum, H, Forbes, A, Tonkin, A, ATACAS Trials Group, Myles, PS, Silbert, BS, Smith, J, Knight, J, Cooper, DJ, McNeil, J, Esmore, DS, Buxton, B, Krum, H, Forbes, A, Tonkin, A, and ATACAS Trials Group
- Abstract
BACKGROUND: Despite some concern that recent aspirin ingestion increases blood loss after coronary artery surgery, there is some evidence that this may reduce thrombotic complications. In contrast, antifibrinolytic drugs can reduce blood loss in this setting, but there is concern that they may increase thrombotic complications. Published guidelines are limited by a lack of large randomized trials addressing the risks and benefits of each of these commonly used therapies in cardiac surgery. The ATACAS Trial is a study comparing aspirin, tranexamic acid, or both, with placebo in patients undergoing on-pump or off-pump coronary artery surgery. METHODS: We discuss the rationale for conducting ATACAS, a 4600-patient, multicenter randomized trial in at-risk coronary artery surgery, and the features of the ATACAS study design (objectives, end points, target population, allocation, treatments, patient follow-up, and analysis). CONCLUSIONS: The ATACAS Trial will be the largest study yet conducted to ascertain the benefits and risks of aspirin and antifibrinolytic therapy in coronary artery surgery. Results of the trial will guide the routine clinical care of patients in this setting.
- Published
- 2008
12. Preexisting cognitive impairment and mild cognitive impairment in subjects presenting for total hip joint replacement.
- Author
-
Evered LA, Silbert BS, Scott DA, Maruff P, Ames D, and Choong PF
- Subjects
- *
ALZHEIMER'S disease diagnosis , *COGNITION disorders diagnosis , *ALZHEIMER'S disease , *COGNITION disorders , *LONGITUDINAL method , *NEUROPSYCHOLOGICAL tests , *PSYCHOLOGICAL factors , *SURGICAL complications , *TOTAL hip replacement , *PSYCHOLOGY , *DIAGNOSIS - Abstract
BACKGROUND: The prevalence of preexisting cognitive impairment (PreCI) is documented before cardiac surgery, but there is less information before noncardiac surgery. In addition, the prevalence of mild cognitive impairment, defined by different cognitive criteria and subjective complaints, and which may progress to Alzheimer disease, is unknown in these subjects. Because anesthesia and surgery have been implicated in Alzheimer disease pathology, we prospectively measured PreCI and mild cognitive impairment in subjects scheduled for total hip joint replacement surgery in an observational study. METHODS: One hundred fifty-two subjects 60 y of age and older who were scheduled for total hip joint replacement surgery underwent assessment, including neuropsychologic testing, 1 week before surgery. Test results were compared with published norms. PreCI was defined as impairment in two or more of seven cognitive tests, for which impairment in an individual test was defined as >= 2 SD below norms for that test. Amnestic mild cognitive impairment (aMCI) was defined as impairment >=1.5 SD below norms for results of the immediate and/or delayed Auditory Verbal Learning Test plus a subjective complaint. RESULTS: Subjects performed worse compared with normative data on five of seven neuropsychologic tests. Thirty (20% [95% CI, 13-26%]) subjects were classified as having PreCI. Thirty-four (22% [95% CI, 16-29%]) were classified as having aMCI. Ten (7%) subjects were classified as having both PreCI and aMCI, representing 33% of the 30 subjects with PreCI. CONCLUSIONS: The prevalence of aMCI in subjects scheduled for total hip joint replacement surgery is similar to that in the general community. PreCI and aMCI tend to identify different subjects. Because aMCI is known to progress to Alzheimer disease, future studies that track cognition before and after anesthesia and surgery should document the presence or absence of aMCI so that the rate of conversion to Alzheimer disease after anesthesia and surgery can be compared with the rate in the nonsurgical population. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. Defining intra-operative hypotension - a pilot comparison of blood pressure during sleep and general anaesthesia*.
- Author
-
Soo JC, Lacey S, Kluger R, and Silbert BS
- Published
- 2011
- Full Text
- View/download PDF
14. Cognitive decline after surgery and illness.
- Author
-
Silbert BS, Evered LA, and Scott DA
- Published
- 2010
- Full Text
- View/download PDF
15. Concurrent intracardiac metastasis in a patient with intestinal perforation.
- Author
-
Lee CT, Farrell S, Silbert BS, Lee, C T, Farrell, S, and Silbert, B S
- Abstract
The administration of anaesthesia to subjects with intracardiac lesions poses the potential for cardiac complications. Cardiac metastases should be identified in susceptible cases and transthoracic echocardiography performed to elucidate the nature of the cardiac lesions. We describe a case of an intracardiac metastasis in a 65-year-old subject with a small bowel tumour leading to intestinal perforation and presenting for surgical treatment. Oncological assessment of the situation, in conjunction with the anaesthetic risks, led to abandonment of surgery and palliative treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2011
16. Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial.
- Author
-
ANZCA Clinical Trials Network, Chan, MTV, Leslie, K, Myles, PS, O'Loughlin, E, Paech, MJ, Peyton, PJ, Silbert, BS, Halliwell, R, Fahlbusch, D, Jefferies, A, Reeves, M, Campbell, D, Beattie, WS, Wijeysundera, DN, Sessler, DI, Wallace, S, Galagher, W, Farrington, C, Ditoro, A, Baulch, S, Sidiropoulos, S, Bulach, R, Bryant, D, Mitteregger, V, Bolsin, S, Osborne, C, McRae, R, Backstrom, M, Cotter, R, March, S, Silbert, B, Said, S, Cope, J, Crump, D, Thompson, G, Buckley, N, Tidy, T, Schricker, T, Lattermann, R, Iannuzzi, D, Carroll, J, Jacka, M, Bryden, C, Badner, N, Tsang, MWY, Cheng, BCP, Fong, ACM, Chu, LCY, Koo, EGY, Mohd, N, Ming, LE, McAllister, D, Walker, S, Olliff, S, Kennedy, R, Eldawlatly, A, Alzahrani, T, Chua, N, Sneyd, R, McMillan, H, Parkinson, I, Brennan, A, Balaji, P, Nightingale, J, Kunst, G, Dickinson, M, Subramaniam, B, Banner-Godspeed, V, Liu, J, Kurz, A, Hesler, B, Fu, AY, Egan, C, Fiffick, AN, Hutcherson MT, Turan, A, Naylor, A, Obal, D, Cooke, E, ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract, ANZCA Clinical Trials Network, Chan, MTV, Leslie, K, Myles, PS, O'Loughlin, E, Paech, MJ, Peyton, PJ, Silbert, BS, Halliwell, R, Fahlbusch, D, Jefferies, A, Reeves, M, Campbell, D, Beattie, WS, Wijeysundera, DN, Sessler, DI, Wallace, S, Galagher, W, Farrington, C, Ditoro, A, Baulch, S, Sidiropoulos, S, Bulach, R, Bryant, D, Mitteregger, V, Bolsin, S, Osborne, C, McRae, R, Backstrom, M, Cotter, R, March, S, Silbert, B, Said, S, Cope, J, Crump, D, Thompson, G, Buckley, N, Tidy, T, Schricker, T, Lattermann, R, Iannuzzi, D, Carroll, J, Jacka, M, Bryden, C, Badner, N, Tsang, MWY, Cheng, BCP, Fong, ACM, Chu, LCY, Koo, EGY, Mohd, N, Ming, LE, McAllister, D, Walker, S, Olliff, S, Kennedy, R, Eldawlatly, A, Alzahrani, T, Chua, N, Sneyd, R, McMillan, H, Parkinson, I, Brennan, A, Balaji, P, Nightingale, J, Kunst, G, Dickinson, M, Subramaniam, B, Banner-Godspeed, V, Liu, J, Kurz, A, Hesler, B, Fu, AY, Egan, C, Fiffick, AN, Hutcherson MT, Turan, A, Naylor, A, Obal, D, Cooke, E, and ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract
- Abstract
BACKGROUND: Globally, >300 million patients have surgery annually, and ≤20% experience adverse postoperative events. We studied the impact of both cardiac and noncardiac adverse events on 1-year disability-free survival after noncardiac surgery. METHODS: We used the study cohort from the Evaluation of Nitrous oxide in Gas Mixture of Anesthesia (ENIGMA-II) trial, an international randomized trial of 6992 noncardiac surgical patients. All were ≥45 years of age and had moderate to high cardiac risk. The primary outcome was mortality within 1 postoperative year. We defined 4 separate types of postoperative adverse events. Major adverse cardiac events (MACEs) included myocardial infarction (MI), cardiac arrest, and myocardial revascularization with or without troponin elevation. MI was defined using the third Universal Definition and was blindly adjudicated. A second cohort consisted of patients with isolated troponin increases who did not meet the definition for MI. We also considered a cohort of patients who experienced major adverse postoperative events (MAPEs), including unplanned admission to intensive care, prolonged mechanical ventilation, wound infection, pulmonary embolism, and stroke. From this cohort, we identified a group without troponin elevation and another with troponin elevation that was not judged to be an MI. Multivariable Cox proportional hazard models for death at 1 year and assessments of proportionality of hazard functions were performed and expressed as an adjusted hazard ratio (aHR) and 95% confidence intervals (CIs). RESULTS: MACEs were observed in 469 patients, and another 754 patients had isolated troponin increases. MAPEs were observed in 631 patients. Compared with control patients, patients with a MACE were at increased risk of mortality (aHR, 3.36 [95% CI, 2.55-4.46]), similar to patients who suffered a MAPE without troponin elevation (n = 501) (aHR, 2.98 [95% CI, 2.26-3.92]). Patients who suffered a MAPE with troponin elevation but withou
17. BS Silbert
- Author
-
Silbert, BS and Silbert, BS
18. Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial.
- Author
-
ANZCA Clinical Trials Network, Chan, MTV, Leslie, K, Myles, PS, O'Loughlin, E, Paech, MJ, Peyton, PJ, Silbert, BS, Halliwell, R, Fahlbusch, D, Jefferies, A, Reeves, M, Campbell, D, Beattie, WS, Wijeysundera, DN, Sessler, DI, Wallace, S, Galagher, W, Farrington, C, Ditoro, A, Baulch, S, Sidiropoulos, S, Bulach, R, Bryant, D, Mitteregger, V, Bolsin, S, Osborne, C, McRae, R, Backstrom, M, Cotter, R, March, S, Silbert, B, Said, S, Cope, J, Crump, D, Thompson, G, Buckley, N, Tidy, T, Schricker, T, Lattermann, R, Iannuzzi, D, Carroll, J, Jacka, M, Bryden, C, Badner, N, Tsang, MWY, Cheng, BCP, Fong, ACM, Chu, LCY, Koo, EGY, Mohd, N, Ming, LE, McAllister, D, Walker, S, Olliff, S, Kennedy, R, Eldawlatly, A, Alzahrani, T, Chua, N, Sneyd, R, McMillan, H, Parkinson, I, Brennan, A, Balaji, P, Nightingale, J, Kunst, G, Dickinson, M, Subramaniam, B, Banner-Godspeed, V, Liu, J, Kurz, A, Hesler, B, Fu, AY, Egan, C, Fiffick, AN, Hutcherson MT, Turan, A, Naylor, A, Obal, D, Cooke, E, ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract, ANZCA Clinical Trials Network, Chan, MTV, Leslie, K, Myles, PS, O'Loughlin, E, Paech, MJ, Peyton, PJ, Silbert, BS, Halliwell, R, Fahlbusch, D, Jefferies, A, Reeves, M, Campbell, D, Beattie, WS, Wijeysundera, DN, Sessler, DI, Wallace, S, Galagher, W, Farrington, C, Ditoro, A, Baulch, S, Sidiropoulos, S, Bulach, R, Bryant, D, Mitteregger, V, Bolsin, S, Osborne, C, McRae, R, Backstrom, M, Cotter, R, March, S, Silbert, B, Said, S, Cope, J, Crump, D, Thompson, G, Buckley, N, Tidy, T, Schricker, T, Lattermann, R, Iannuzzi, D, Carroll, J, Jacka, M, Bryden, C, Badner, N, Tsang, MWY, Cheng, BCP, Fong, ACM, Chu, LCY, Koo, EGY, Mohd, N, Ming, LE, McAllister, D, Walker, S, Olliff, S, Kennedy, R, Eldawlatly, A, Alzahrani, T, Chua, N, Sneyd, R, McMillan, H, Parkinson, I, Brennan, A, Balaji, P, Nightingale, J, Kunst, G, Dickinson, M, Subramaniam, B, Banner-Godspeed, V, Liu, J, Kurz, A, Hesler, B, Fu, AY, Egan, C, Fiffick, AN, Hutcherson MT, Turan, A, Naylor, A, Obal, D, Cooke, E, and ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract
- Abstract
BACKGROUND: Globally, >300 million patients have surgery annually, and ≤20% experience adverse postoperative events. We studied the impact of both cardiac and noncardiac adverse events on 1-year disability-free survival after noncardiac surgery. METHODS: We used the study cohort from the Evaluation of Nitrous oxide in Gas Mixture of Anesthesia (ENIGMA-II) trial, an international randomized trial of 6992 noncardiac surgical patients. All were ≥45 years of age and had moderate to high cardiac risk. The primary outcome was mortality within 1 postoperative year. We defined 4 separate types of postoperative adverse events. Major adverse cardiac events (MACEs) included myocardial infarction (MI), cardiac arrest, and myocardial revascularization with or without troponin elevation. MI was defined using the third Universal Definition and was blindly adjudicated. A second cohort consisted of patients with isolated troponin increases who did not meet the definition for MI. We also considered a cohort of patients who experienced major adverse postoperative events (MAPEs), including unplanned admission to intensive care, prolonged mechanical ventilation, wound infection, pulmonary embolism, and stroke. From this cohort, we identified a group without troponin elevation and another with troponin elevation that was not judged to be an MI. Multivariable Cox proportional hazard models for death at 1 year and assessments of proportionality of hazard functions were performed and expressed as an adjusted hazard ratio (aHR) and 95% confidence intervals (CIs). RESULTS: MACEs were observed in 469 patients, and another 754 patients had isolated troponin increases. MAPEs were observed in 631 patients. Compared with control patients, patients with a MACE were at increased risk of mortality (aHR, 3.36 [95% CI, 2.55-4.46]), similar to patients who suffered a MAPE without troponin elevation (n = 501) (aHR, 2.98 [95% CI, 2.26-3.92]). Patients who suffered a MAPE with troponin elevation but withou
19. BS Silbert
- Author
-
Silbert, BS and Silbert, BS
20. Surgery outcomes in those with neurocognitive disorders.
- Author
-
Silbert BS, Scott DA, and Evered LA
- Subjects
- Humans, Neurocognitive Disorders surgery, Cognition Disorders etiology, Cognition Disorders surgery, Cognition Disorders psychology
- Abstract
Competing Interests: We declare no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
21. Examining Subjective Psychological Experiences of Postoperative Delirium in Older Cardiac Surgery Patients.
- Author
-
Cohen CL, Atkins KJ, Evered LA, Silbert BS, and Scott DA
- Subjects
- Humans, Middle Aged, Aged, Cognition, Postoperative Complications diagnosis, Postoperative Complications etiology, Risk Factors, Emergence Delirium etiology, Delirium diagnosis, Delirium etiology, Delirium psychology, Cognitive Dysfunction etiology, Cardiac Surgical Procedures adverse effects
- Abstract
Background: Postoperative delirium (POD) is an acute syndrome including inattention and impaired cognition that affects approximately 42% of older cardiac surgical patients. POD is linked to adverse outcomes including morbidity, mortality, and further cognitive decline. Less is known about the subjective psychological experience of POD and its ongoing impact on well-being., Methods: We performed a qualitative analysis of the long-term psychological sequelae of older adults who experience POD after cardiac surgery. We sampled 30 patients aged 60 years and older who experienced at least 2 episodes of POD during a prior hospital admission. We administered semistructured interviews with participants via telephone 3 to 5 years postoperatively. Interviews were transcribed and thematically analyzed. Data were interpreted in accordance with the naturalist paradigm., Results: Three overarching themes emerged in our qualitative analysis. The first reflected the multifaceted presentation of POD, including distortion of time and reality; feelings of isolation; and a loss of self, identity, and control. The second theme reflected the psychological challenges associated with functional decline after surgery. Common examples of functional decline included cognitive difficulties, excessive fatigue, and a perceived loss of independence. The final theme captured the emotional sequelae of acute illness, which included low mood, reduced motivation, and social comparisons., Conclusions: Our findings emphasize the multidimensional experience of POD and long-term effects on psychological wellbeing. Our research highlights the beneficial role multidisciplinary clinicians play in managing POD including strategies that may be embedded into clinical practice and helps anesthesiologists understand why patients who have experienced POD in the past may present with specific concerns should they require subsequent surgery., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2022 International Anesthesia Research Society.)
- Published
- 2023
- Full Text
- View/download PDF
22. Inflammatory Biomarker Levels After Propofol or Sevoflurane Anesthesia: A Meta-analysis.
- Author
-
O'Bryan LJ, Atkins KJ, Lipszyc A, Scott DA, Silbert BS, and Evered LA
- Subjects
- Anesthesia, General, Anesthetics, Anesthetics, Inhalation adverse effects, Anesthetics, Intravenous adverse effects, C-Reactive Protein biosynthesis, Cognition, Humans, Inflammation, Interleukin-10 blood, Interleukin-6 blood, Perioperative Period, Propofol adverse effects, Randomized Controlled Trials as Topic, Sevoflurane adverse effects, Tumor Necrosis Factor-alpha blood, Biomarkers blood, Propofol therapeutic use, Sevoflurane therapeutic use
- Abstract
Background: The perioperative inflammatory response may be implicated in adverse outcomes including neurocognitive dysfunction and cancer recurrence after oncological surgery. The immunomodulatory role of anesthetic agents has been demonstrated in vitro; however, its clinical relevance is unclear. The purpose of this meta-analysis was to compare propofol and sevoflurane with respect to biomarkers of perioperative inflammation. The secondary aim was to correlate markers of inflammation with clinical measures of perioperative cognition., Methods: Databases were searched for randomized controlled trials examining perioperative inflammation after general anesthesia using propofol compared to sevoflurane. Inflammatory biomarkers investigated were interleukin (IL)-6, IL-10, tissue necrosis factor alpha (TNF-α), and C-reactive protein (CRP). The secondary outcome was incidence of perioperative neurocognitive disorders. Meta-analysis with metaregression was performed to determine the difference between propofol and sevoflurane., Results: Twenty-three studies were included with 1611 participants. Studies varied by surgery type, duration, and participant age. There was an increase in the mean inflammatory biomarker levels following surgery, with meta-analysis revealing no difference in effect between propofol and sevoflurane. Heterogeneity between studies was high, with surgery type, duration, and patient age contributing to the variance across studies. Only 5 studies examined postoperative cognitive outcomes; thus, a meta-analysis could not be performed. Nonetheless, of these 5 studies, 4 reported a reduced incidence of cognitive decline associated with propofol use., Conclusions: Surgery induces an inflammatory response; however, the inflammatory response did not differ as a function of anesthetic technique. This absence of an effect suggests that patient and surgical variables may have a far more significant impact on the postoperative inflammatory responses than anesthetic technique. The majority of studies assessing perioperative cognition in older patients reported a benefit associated with the use of propofol; however, larger trials using homogenous outcomes are needed to demonstrate such an effect., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2021 International Anesthesia Research Society.)
- Published
- 2022
- Full Text
- View/download PDF
23. Impaired cognitive performance on MoCA testing at discharge in elderly patients following day endoscopy and its relationship to preoperative mild cognitive impairment.
- Author
-
Chua NJ, Dimopoulos G, Scott DA, Silbert BS, and Evered LA
- Subjects
- Aged, Cognition, Cohort Studies, Endoscopy, Humans, Cognitive Dysfunction diagnosis, Cognitive Dysfunction epidemiology, Patient Discharge
- Abstract
In patients admitted to hospital, preoperative mild cognitive impairment predicts postoperative complications. The effect of mild cognitive impairment on discharge readiness among the day stay surgery population is unknown. Our aims were to determine the incidence of impaired cognitive performance at discharge after day stay endoscopy and whether pre-existing mild cognitive impairment was associated with its development. A single-centre cohort study of elective day stay endoscopy patients was undertaken. Over a three-month period, data were collected from 69 patients aged 65 years and over. Patients were cognitively assessed on admission and discharge using the Montreal cognitive assessment tool and the three-minute diagnostic confusion assessment method. At baseline, patients who scored 1.5 or more standard deviations below age-adjusted levels on the Montreal cognitive assessment tool in conjunction with a subjective memory complaint were classified as having mild cognitive impairment. At discharge, patients were classified as having impaired cognitive performance if there was a reduction in the Montreal cognitive assessment tool score by at least two points. We also assessed delirium and subsyndromal delirium at discharge using the three-minute diagnostic confusion assessment method. We identified mild cognitive impairment in 23 patients (33.3%) on admission, and impaired performance on the Montreal cognitive assessment tool test at discharge in 35 (50.7%) patients. There was no association between mild cognitive impairment on admission and impaired cognitive performance at discharge (50.0% versus 51.1%, P = 0.94). This study demonstrates that evidence of impaired cognitive performance on the Montreal cognitive assessment tool testing is present after day stay endoscopy in over 50% of elderly patients, but this is not associated with preoperative cognitive status.
- Published
- 2021
- Full Text
- View/download PDF
24. Informed Consent in Patients With Frailty Syndrome.
- Author
-
Silbert BS and Scott DA
- Subjects
- Aged, Ageism, Anesthesia methods, Anesthesiology legislation & jurisprudence, Biomedical Research trends, Ethics, Research, Frail Elderly, Frailty complications, Frailty psychology, Humans, Length of Stay, Neurocognitive Disorders complications, Outcome Assessment, Health Care, Preoperative Period, Prevalence, Risk, Anesthesia adverse effects, Anesthesia ethics, Frailty surgery, Informed Consent
- Abstract
Frailty is present in more than 30% of individuals older than 65 years of age presenting for anesthesia and surgery, and poses a number of unique issues in the informed consent process. Much attention has been directed at the increased incidence of poor outcomes in these individuals, including postoperative mortality, complications, and prolonged length of stay. These material risks are not generally factored into conventional risk predictors, so it is likely that individuals with frailty are never fully informed of the true risk for procedures undertaken in the hospital setting. While the term "frailty" has the advantage of alerting to risk and allowing appropriate care and interventions, the term has the social disadvantage of encouraging objectivity to ageism. This may encourage paternalistic behavior from carers and family encroaching on self-determination and, in extreme cases, manifesting as coercion and compromising autonomy. There is a high prevalence of neurocognitive disorder in frail elderly patients, and care must be taken to identify those without capacity to provide informed consent; equally important is to not exclude those with capacity from providing consent. Obtaining consent for research adds an extra onus to that of clinical consent. The informed consent process in the frail elderly poses unique challenges to the busy clinical anesthesiologist. At the very least, an increased time commitment should be recognized. The gap between theoretical goals and actual practice of informed consent should be acknowledged.
- Published
- 2020
- Full Text
- View/download PDF
25. Postoperative Cognitive Dysfunction and Noncardiac Surgery.
- Author
-
Evered LA and Silbert BS
- Subjects
- Adult, Aged, Aged, 80 and over, Anesthesia, General adverse effects, Anesthesiology methods, Cognition, Cognitive Dysfunction complications, Delirium etiology, Geriatrics, Humans, Middle Aged, Neuropsychological Tests, Postoperative Complications diagnosis, Postoperative Period, Risk Factors, Anesthesia adverse effects, Cognitive Dysfunction etiology, Surgical Procedures, Operative adverse effects
- Abstract
Postoperative cognitive dysfunction (POCD) is an objectively measured decline in cognition postoperatively compared with preoperative function. POCD has been considered in the anesthetic and surgical literature in isolation of cognitive decline which is common in the elderly within the community and where it is labeled as mild cognitive impairment, neurocognitive disorder, or dementia. This narrative review seeks to place POCD in the broad context of cognitive decline in the general population. Cognitive change after anesthesia and surgery was described over 100 years ago, initially as delirium and dementia. The term POCD was applied in the 1980s to refer to cognitive decline assessed purely on the basis of a change in neuropsychological test results, but the construct has been the subject of great heterogeneity. The cause of POCD remains unknown. Increasing age, baseline cognitive impairment, and fewer years of education are consistently associated with POCD.In geriatric medicine, cognitive disorders defined and classified as mild cognitive impairment, neurocognitive disorder, and dementia have definitive clinical features. To identify the clinical impact of cognitive impairment associated with the perioperative period, POCD has recently been redefined in terms of these geriatric medicine constructs so that the short-, medium-, and long-term clinical and functional impact can be elucidated. As the aging population present in ever increasing numbers for surgery, many individuals with overt or subclinical dementia require anesthesia. Anesthesiologists must be equipped to understand and manage these patients.
- Published
- 2018
- Full Text
- View/download PDF
26. Cognitive Function Before and After Left Heart Catheterization.
- Author
-
Scott DA, Evered L, Maruff P, MacIsaac A, Maher S, and Silbert BS
- Subjects
- Aged, Cognitive Dysfunction diagnosis, Cognitive Dysfunction epidemiology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Neuropsychological Tests, Prevalence, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, Victoria epidemiology, Cardiac Catheterization adverse effects, Cognition, Cognitive Dysfunction psychology
- Abstract
Background: Hospital procedures have been associated with cognitive change in older patients. This study aimed to document the prevalence of mild cognitive impairment in individuals undergoing left heart catheterization (LHC) before the procedure and the incidence of cognitive decline to 3 months afterwards., Methods and Results: We conducted a prospective, observational, clinical investigation of elderly participants undergoing elective LHC. Cognition was assessed using a battery of written tests and a computerized cognitive battery before the LHC and then at 3 months afterwards. The computerized tests were also administered at 24 hours (or discharge) and 7 days after LHC. A control group of 51 community participants was recruited to calculate cognitive decline using the Reliable Change Index. Of 437 participants, mild cognitive impairment was identified in 226 (51.7%) before the procedure. Computerized tests detected an incidence of cognitive decline of 10.0% at 24 hours and 7.5% at 7 days. At 3 months, written tests detected an incidence of cognitive decline of 13.1% and computerized tests detected an incidence of 8.5%. Cognitive decline at 3 months using written tests was associated with increasing age, whereas computerized tests showed cognitive decline was associated with baseline amnestic mild cognitive impairment, diabetes mellitus, and prior coronary stenting., Conclusions: More than half the patients aged >60 years presenting for LHC have mild cognitive impairment. LHC is followed by cognitive decline in 8% to 13% of individuals at 3 months after the procedure. Subtle cognitive decline both before and after LHC is common and may have important clinical implications., Clinical Trial Registration Information: URL: www.anzctr.org.au. Unique identifier: ACTRN12607000051448., (© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.)
- Published
- 2018
- Full Text
- View/download PDF
27. Prevalence of Dementia 7.5 Years after Coronary Artery Bypass Graft Surgery.
- Author
-
Evered LA, Silbert BS, Scott DA, Maruff P, and Ames D
- Subjects
- Aged, Aged, 80 and over, Cognition Disorders etiology, Cognitive Dysfunction etiology, Cognitive Dysfunction psychology, Coronary Artery Bypass mortality, Delirium etiology, Dementia etiology, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Peripheral Vascular Diseases complications, Peripheral Vascular Diseases epidemiology, Postoperative Complications epidemiology, Postoperative Complications psychology, Prevalence, Prospective Studies, Risk Factors, Coronary Artery Bypass adverse effects, Coronary Artery Bypass psychology, Dementia epidemiology, Dementia psychology
- Abstract
Background: Although postoperative cognitive dysfunction (POCD) is well described after coronary artery bypass graft (CABG) surgery, a major concern has been that a progressive decline in cognition will ultimately lead to dementia. Since dementia interferes with the ability to carry out daily functions, the impact has far greater ramifications than cognitive decline defined purely by a decreased ability to perform on a battery of neurocognitive tests. The authors hypothesized that early cognitive impairment measured as baseline cognitive impairment is associated with an increased risk of long-term dementia., Methods: The authors conducted a prospective longitudinal study on 326 patients aged 55 yr and older at the time of undergoing CABG surgery. Dementia was classified by expert opinion on review of performance on the Clinical Dementia Rating Scale and several other assessment tasks. Patients were also assessed for POCD at 3 and 12 months and at 7.5 yr using a battery of neuropsychologic tests and classified using the reliable change index. Associations were assessed using univariable analysis., Results: At 7.5 yr after CABG surgery, the prevalence of dementia was 36 of 117 patients (30.8%; 95% CI, 23 to 40). POCD was detected in 62 of 189 patients (32.8%; 95% CI, 26 to 40). Due to incomplete assessments, the majority (113 patients), but not all, were assessed for both dementia and POCD. Fourteen of 32 (44%) patients with dementia were also classified as having POCD. Preexisting cognitive impairment and peripheral vascular disease were both associated with dementia 7.5 yr after CABG surgery. POCD at both 3 (odds ratio, 3.06; 95% CI, 1.39 to 9.30) and 12 months (odds ratio, 4.74; 95% CI, 1.63 to 13.77) was associated with an increased risk of mortality by 7.5 yr., Conclusions: The prevalence of dementia at 7.5 yr after CABG surgery is greatly increased compared to population prevalence. Impaired cognition before surgery or the presence of cardiovascular disease may contribute to the high prevalence.
- Published
- 2016
- Full Text
- View/download PDF
28. Incidence of postoperative cognitive dysfunction after general or spinal anaesthesia for extracorporeal shock wave lithotripsy.
- Author
-
Silbert BS, Evered LA, and Scott DA
- Subjects
- Aged, Aged, 80 and over, Cognition Disorders psychology, Female, Humans, Incidence, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, Anesthesia, General adverse effects, Anesthesia, Spinal adverse effects, Cognition Disorders epidemiology, Cognition Disorders etiology, Lithotripsy adverse effects, Postoperative Complications epidemiology, Postoperative Complications psychology
- Abstract
Background: Since general anaesthesia invariably accompanies surgery, the contribution of each to the development of postoperative cognitive dysfunction (POCD) has been difficult to identify., Methods: A prospective randomized controlled trial was undertaken in elderly patients undergoing extracorporeal shock wave lithotripsy (ESWL). Between 2005 and 2011, 2706 individuals were screened to recruit 100 eligible patients. Patients were randomly assigned to receive general or spinal anaesthesia alone. A battery of eight neuropsychological tests was administered before operation and at 7 days and 3 months after operation. The reliable change index was used to calculate the incidence of POCD. Intention-to-treat analysis was used to compare rates of POCD., Results: Futility analysis led to stopping of the trial after recruitment of 100 patients. Fifty patients were randomly assigned to general anaesthesia, and 48 patients to spinal anaesthesia without sedation or postoperative opioids. At 3 months, POCD was detected in 6.8% [95% confidence interval (CI): 1.4-18.7%] of patients in the general anaesthesia group and 19.6% (95% CI: 9.4-33.9%) in the spinal group (P=0.07). At 7 days after operation, the incidence of POCD was 4.1% (95% CI: 0.5-14%) in the general anaesthesia group and 11.9% (95% CI: 4.0-26.6%) in the spinal group (P=0.16)., Conclusions: We found no significant difference in the rates of POCD when comparing general anaesthesia with spinal anaesthesia, suggesting that the surgical or procedural process itself may contribute to the development of POCD., Clinical Trial Registration: Australian Clinical Trials Registry number ACTRN12605000150640., (© The Author 2014. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
29. Review of transcranial Doppler ultrasound to detect microemboli during orthopedic surgery.
- Author
-
Silbert BS, Evered LA, Scott DA, Rahardja S, Gerraty RP, and Choong PF
- Subjects
- Female, Humans, Male, Middle Aged, Orthopedics, Intracranial Embolism diagnostic imaging, Middle Cerebral Artery diagnostic imaging, Orthopedic Procedures adverse effects, Ultrasonography, Doppler, Transcranial methods
- Abstract
Transcranial Doppler ultrasonography has been used to detect microemboli in the middle cerebral artery during orthopedic surgery. We conducted a comprehensive systematic literature review of transcranial Doppler ultrasonography in orthopedic surgery to evaluate its status in this setting. Fourteen studies were selected for qualitative analysis. The highest number of patients studied was 45; emboli were detected in all studies, occurring in 20%-100% of patients. Most embolic counts were below 10, but some high counts were noted. No study reported all the technical parameters of the transcranial Doppler ultrasonography. All studies assessed neurologic status, and 6 studies evaluated cognitive function postoperatively. No study identified an association between postoperative cognitive function and embolic count. Six studies sought the presence of right-to-left shunts., (© 2014 by American Journal of Neuroradiology.)
- Published
- 2014
- Full Text
- View/download PDF
30. Cognitive dysfunction follows left heart catheterisation but is not related to microembolic count.
- Author
-
Scott DA, Evered LA, Gerraty RP, MacIsaac A, Lai-Kwon J, and Silbert BS
- Subjects
- Aged, Cardiac Catheterization trends, Cognition Disorders psychology, Cohort Studies, Coronary Angiography trends, Embolism etiology, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, Cardiac Catheterization adverse effects, Cognition Disorders diagnostic imaging, Cognition Disorders etiology, Coronary Angiography adverse effects, Embolism diagnostic imaging, Microcirculation physiology
- Abstract
Background: Left heart catheterisation with coronary angiography (CA) may lead to cognitive dysfunction, as a result of neurological injury. The aim was to assess the incidence of cognitive dysfunction in elderly patients three months after CA and investigate any association between cognitive dysfunction and microembolic count during CA., Methods: This was a prospective observational study with a control cohort. Cognitive testing was undertaken at baseline and at 3 months using a battery of 8 neuropsychological tests. Subjects comprised 51 CA patients, aged ≥ 50 years, with normal baseline cognition, and 31 community control participants. Microemboli were measured by Transcranial Doppler throughout the procedure. All patients underwent trans-femoral CA with aortography and ventriculography. Cognitive dysfunction was defined in an individual when their reliable change index score was less than -1.96 on 2 or more tests and/or their combined z score was less than -1.96. Microembolic count was assessed by off-line manual counting and automatic software was also used to count and differentiate gaseous from solid microemboli., Results: Cognitive dysfunction was identified in 15.7% of patients at 3 months. Microemboli were detected in all patients, predominantly during aortography and ventriculography. The median total embolic count was 365 (IQR 192, 574), the majority being gaseous (84%). There was no multivariable association between cognitive dysfunction at 3 months and microembolic count., Conclusions: This study demonstrated that cognitive dysfunction following CA is not associated with microembolic load. Cognitive dysfunction occurs in 15.7% of patients at 3 months. This is reassuring for the proceduralist and suggests that other perioperative elements are involved., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
31. The devil is in the detail.
- Author
-
Evered LA, Scott DA, and Silbert BS
- Subjects
- Female, Humans, Male, Angioplasty, Cognition, Coronary Artery Bypass, Off-Pump, Percutaneous Coronary Intervention
- Published
- 2014
- Full Text
- View/download PDF
32. Cardiac surgery, the brain, and inflammation.
- Author
-
Scott DA, Evered LA, and Silbert BS
- Subjects
- Causality, Cognition Disorders prevention & control, Comorbidity, Encephalitis prevention & control, Humans, Incidence, Postoperative Complications prevention & control, Risk Assessment, Cardiac Surgical Procedures statistics & numerical data, Cognition Disorders epidemiology, Encephalitis epidemiology, Evidence-Based Medicine, Postoperative Complications epidemiology
- Abstract
Cognitive deterioration can reliably be measured after procedures requiring anesthesia and surgery. Cardiac surgery has had the spotlight because of the high reported incidence of postoperative cognitive dysfunction in early studies, but such effects occur after other surgical procedures as well. "Early" postoperative cognitive dysfunction should be considered as a different phenomenon, relating to acute pharmacological, physiological, and stress-related recovery. The focus should be on what is affecting patients at 3 months, 12 months, and 5 years later. Like with many other aspects of perioperative risk, a significant element is the patient's preoperative cognitive status. We now know that up to one-third of overtly "normal" elective cardiac surgical patients enter surgery with some degree of pre-existing cognitive impairment or, when applying psychogeriatric measures, mild cognitive impairment. The latter is a known prodrome or early stage of the amyloid associated Alzheimer's disease dementia. Inflammatory responses during cardiac surgery have been recognized for years, but our understanding of the complexity of systemic inflammatory response has grown significantly with the ability to assay neurohumoral markers such as interleukins. The blood-brain barrier is made vulnerable by both pre-existing disorders (mild cognitive impairment/amyloid; vascular disease) and by the inflammatory response to surgery and cardiopulmonary bypass. Inflammation affecting the brain at this time may set in motion accelerated neurological and hence cognitive decline that, despite an initial recovery and even functional improvement, may proceed to further long-term decline at an accelerated rate in susceptible individuals. Clinical data are emerging from longer-term studies to support this concern, but evidence for effective preventive or therapeutic strategies is limited.
- Published
- 2014
33. Anesthesia and Alzheimer's disease: time to wake up!
- Author
-
Scott DA, Silbert BS, and Evered LA
- Subjects
- Alzheimer Disease epidemiology, Alzheimer Disease psychology, Cognition Disorders epidemiology, Cognition Disorders psychology, Humans, Postoperative Complications epidemiology, Postoperative Complications etiology, Alzheimer Disease complications, Anesthesia adverse effects, Cognition Disorders chemically induced, Postoperative Complications psychology
- Published
- 2013
- Full Text
- View/download PDF
34. Aprotinin, but not tranexamic acid, is associated with increased pulmonary microvascular fibrin deposition after cardiac surgery.
- Author
-
Dixon B, Nixon I, Kenny J, Newcomb AE, Rosalion A, Opeskin K, Stamaratis G, Silbert BS, Said S, Santamaria JD, and Campbell DJ
- Subjects
- Aged, Aged, 80 and over, Case-Control Studies, Humans, Lung drug effects, Lung pathology, Male, Middle Aged, Antifibrinolytic Agents adverse effects, Aprotinin adverse effects, Fibrin metabolism, Lung blood supply, Microcirculation drug effects, Thoracic Surgery, Tranexamic Acid adverse effects
- Published
- 2011
- Full Text
- View/download PDF
35. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.
- Author
-
Leslie K, Myles PS, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, and Williamson E
- Subjects
- Aged, Anesthetics, Inhalation administration & dosage, Biomarkers blood, Cause of Death, Chi-Square Distribution, Female, Follow-Up Studies, Homocysteine blood, Humans, Logistic Models, Male, Middle Aged, Myocardial Infarction blood, Nitrous Oxide administration & dosage, Odds Ratio, Proportional Hazards Models, Risk Assessment, Risk Factors, Stroke etiology, Stroke mortality, Surgical Procedures, Operative, Survival Rate, Time Factors, Treatment Outcome, Anesthetics, Inhalation adverse effects, Myocardial Infarction etiology, Myocardial Infarction mortality, Nitrous Oxide adverse effects
- Abstract
Background: There is a plausible pathophysiologic rationale for increased long-term cardiovascular morbidity and mortality in patients receiving significant exposure to nitrous oxide. However, this relationship has not been established clinically. The ENIGMA trial randomized 2050 patients having noncardiac surgery lasting more than 2 hours to nitrous oxide-based or nitrous oxide-free anesthesia. We conducted a follow-up study of the ENIGMA patients to evaluate the risk of cardiovascular events in the longer term., Methods: The trial case report forms and medical records of all study patients were reviewed. The date and cause of death and occurrence of myocardial infarction or stroke were recorded. A telephone interview was then conducted with all surviving patients. The primary endpoint of the study was survival., Results: The median follow-up time was 3.5 (range: 0 to 5.7) years. Three hundred eighty patients (19%) had died since the index surgery, 91 (4.5%) were recorded as having myocardial infarction, and 44 (2.2%) had a stroke during the entire follow-up period. Nitrous oxide did not significantly increase the risk of death [hazard ratio = 0.98 (95% confidence interval, CI: 0.80 to 1.20; P = 0.82)]. The adjusted odds ratio for myocardial infarction in patients administered nitrous oxide was 1.59 (95% CI: 1.01 to 2.51; P = 0.04) and for stroke was 1.01 (95% CI: 0.55 to 1.87; P = 0.97)., Conclusions: The administration of nitrous oxide was associated with increased long-term risk of myocardial infarction, but not of death or stroke in patients enrolled in the ENIGMA trial. The exact relationship between nitrous oxide administration and serious long-term adverse outcomes will require confirmation by an appropriately designed large randomized controlled trial.
- Published
- 2011
- Full Text
- View/download PDF
36. Cognitive function in patients undergoing coronary angiography.
- Author
-
Devapalasundarum AN, Silbert BS, Evered LA, Scott DA, MacIsaac AI, and Maruff PT
- Abstract
Objective: To measure cognition in patients before and after coronary angiography., Design: Prospective observational cohort study., Setting: University teaching hospital., Patients: 56 patients presenting for elective coronary angiography., Main Outcome Measures: Computerised cognitive test battery administered before coronary angiography, before discharge from hospital and 7 days after discharge. A matched healthy control group was used as a comparator., Results: When analysed by group, coronary angiography patients performed worse than matched controls at each time point. When the cognitive change was examined for each individual, of the 48 patients tested at discharge, 19 (39.6%) were classified as having a new cognitive dysfunction, and of 49 patients tested at day 7, six (12.2%) were classified as having a new cognitive dysfunction., Conclusions: The results confirm that cognitive function is decreased in patients who have cardiovascular disease. Furthermore, coronary angiography may exacerbate this impaired cognition in some patients.
- Published
- 2010
- Full Text
- View/download PDF
37. Postoperative cognitive dysfunction and aortic atheroma.
- Author
-
Evered LA, Silbert BS, and Scott DA
- Subjects
- Aged, Aortic Diseases epidemiology, Atherosclerosis epidemiology, Cognition Disorders epidemiology, Female, Humans, Male, Postoperative Complications epidemiology, Time Factors, Aortic Diseases complications, Atherosclerosis complications, Cognition Disorders etiology, Coronary Artery Bypass, Postoperative Complications etiology
- Abstract
Background: The relationship of aortic atheroma to postoperative cognitive dysfunction (POCD), a common complication of coronary artery bypass graft surgery, has not been resolved. We undertook assessment of aortic atheroma using intraoperative ultrasonography and related the degree of aortic atheroma to POCD., Methods: Aortic atheroma was assessed using intraoperative transesophageal and epiaortic echocardiography in 311 patients who underwent coronary artery bypass graft surgery. Atheroma was graded from 0 (normal or minimal) to 3 (mobile or rough) in each of four quadrants of the proximal ascending to proximal descending thoracic aorta. Atheroma burden was defined as the atheroma score divided by the total possible score for that patient. Patients also completed a neuropsychological battery consisting of eight tests taken the week before surgery and at 1 week and 3 and 12 months afterward. Decreased cognitive function for each test was defined as an individual decrease of at least 1 standard deviation of the group baseline mean for that test, and POCD was defined as a decrease in two or more tests., Results: The atheroma burden (%) was greater in the patients with POCD. The difference was greatest at 1 week (10.4+/-14.7 versus 4.4+/-9.0, p=0.0002) and diminished progressively at 3 months (8.9+/-14.1 versus 5.4+/-10.1, p=0.06) and 12 months (6.6+/-12.0 versus 5.6+/-10.2, p=0.56). Multivariable analysis showed that atheroma burden strongly predicted POCD at 1 week., Conclusions: Aortic atheroma burden predicts POCD at 1 week but has less impact on POCD as time progresses. Atheroma burden is highly correlated with age and may be a good predictor of early POCD., (Copyright (c) 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
38. Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery.
- Author
-
Evered LA, Silbert BS, Scott DA, Maruff P, Laughton KM, Volitakis I, Cowie T, Cherny RA, Masters CL, and Li QX
- Subjects
- Aged, Cognition Disorders diagnosis, Female, Humans, Male, Neuropsychological Tests, Time Factors, Amyloid beta-Peptides blood, Cognition Disorders blood, Cognition Disorders etiology, Coronary Artery Bypass adverse effects, Peptide Fragments blood
- Abstract
Background: Decreased cognitive function associated with coronary artery bypass graft surgery is common. These deficits may be similar to the cognitive dysfunction seen in the spectrum of mild cognitive impairment to Alzheimer's disease, which are believed to result from the accumulation of amyloid beta (Abeta) peptide in the brain. We measured cognition both before and after coronary artery bypass graft surgery and assayed Abeta levels to investigate whether the cognitive dysfunction of cardiac surgery was associated with Abeta levels., Methods: The plasma of 332 patients, who had undergone neuropsychological testing before and 3 and 12 months after coronary artery bypass graft surgery, was analyzed for Abeta(42) and Abeta(40). Patients were classified as having preexisting cognitive impairment if cognitive function was decreased in two or more tests compared with a healthy control group, and postoperative cognitive dysfunction was defined as a decline in two or more tests compared with the group mean baseline score., Results: Preexisting cognitive impairment was present in 117 patients (35.2%), and postoperative cognitive dysfunction was present in 40 (12%) at 3 months and 41 (13%) at 12 months after surgery. Both plasma Abeta(42) and Abeta(40) levels assessed before the surgery were significantly lower in patients who later had postoperative cognitive dysfunction at 3 months., Conclusions: Decreased preoperative plasma levels of Abeta(42) and Abeta(40) in patients who exhibit postoperative cognitive dysfunction at 3 months suggest that postoperative cognitive dysfunction at this time may share a common mechanism with mild cognitive impairment and Alzheimer's disease. This process may be exacerbated by anesthesia.
- Published
- 2009
- Full Text
- View/download PDF
39. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol.
- Author
-
Padmanabhan U, Leslie K, Eer AS, Maruff P, and Silbert BS
- Subjects
- Adult, Ambulatory Surgical Procedures, Anesthesia Recovery Period, Awareness drug effects, Double-Blind Method, Dreams drug effects, Elective Surgical Procedures, Electroencephalography, Female, Fentanyl adverse effects, Humans, Hypnotics and Sedatives adverse effects, Male, Mental Recall drug effects, Midazolam adverse effects, Middle Aged, Monitoring, Intraoperative methods, Patient Discharge, Patient Satisfaction, Propofol adverse effects, Time Factors, Cognition drug effects, Colonoscopy, Conscious Sedation methods, Fentanyl administration & dosage, Hypnotics and Sedatives administration & dosage, Midazolam administration & dosage, Propofol administration & dosage
- Abstract
Background: The sedative drug combination that produces minimal cognitive impairment and optimal operating conditions during colonoscopy has not been determined. We sought to determine if the use of propofol alone results in less cognitive impairment at discharge than the use of propofol plus midazolam and/or fentanyl in patients presenting for elective outpatient colonoscopy., Methods: Two hundred adult patients presenting for elective outpatient colonoscopy were randomized to receive propofol alone or propofol plus midazolam, and/or fentanyl for IV sedation. Baseline cognitive function was measured using the computerized CogState test battery (Cogstate, Melbourne, Australia) before sedation. During the procedure, sedative drug doses, depth of sedation (via the bispectral index and observer's assessment of alertness/sedation score), complications, and treatability were recorded. Patients were interviewed about recall immediately after emerging from sedation, and cognitive testing was repeated at hospital discharge. Recovery times, quality of recovery, and satisfaction with care were also recorded., Results: In the propofol plus adjuvants group, 84 patients received fentanyl 50 microg (25-100) (median [range]) and 57 patients received midazolam 2 mg (0.5-10). Patients' cognitive function at discharge was worse than their performance at baseline. However, the changes in cognitive function between discharge and baseline were not significantly different between the two groups. At discharge, 18.5% of patients were cognitively impaired to an extent equivalent to a blood-alcohol concentration of 0.05%. Sedation with propofol plus midazolam and/or fentanyl produced better operating conditions than sedation with propofol alone and was associated with shorter procedure times. Recovery times, recall, dreaming, quality of recovery, and patient satisfaction with care were similar between the groups. Administration of >2 mg of midazolam was a predictor of impaired cognitive function at discharge., Conclusions: Significant cognitive impairment was common at discharge from elective outpatient colonoscopy. However, the addition of midazolam and/or fentanyl to propofol sedation did not result in more cognitive impairment than the use of propofol alone. Furthermore, the use of adjuvants improved the ease of colonoscopy without increasing the rate of complications or prolonging early recovery times..
- Published
- 2009
- Full Text
- View/download PDF
40. Is fast-track cardiac anesthesia now the global standard of care?
- Author
-
Silbert BS and Myles PS
- Subjects
- Anesthesia economics, Cardiac Surgical Procedures economics, Clinical Trials as Topic, Critical Care economics, Humans, Intensive Care Units economics, Retrospective Studies, Anesthesia standards, Anesthesia trends, Cardiac Surgical Procedures standards, Cardiac Surgical Procedures trends
- Published
- 2009
- Full Text
- View/download PDF
41. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design.
- Author
-
Myles PS, Leslie K, Peyton P, Paech M, Forbes A, Chan MT, Sessler D, Devereaux PJ, Silbert BS, Jamrozik K, Beattie S, Badner N, Tomlinson J, and Wallace S
- Subjects
- Aged, Cardiovascular Diseases epidemiology, Female, Humans, Length of Stay, Male, Pneumonia epidemiology, Research Design, Risk Assessment, Surgical Procedures, Operative, Surgical Wound Infection epidemiology, Vomiting epidemiology, Anesthetics, Inhalation adverse effects, Cardiovascular Diseases etiology, Homocysteine blood, Nitrous Oxide adverse effects, Postoperative Complications epidemiology
- Abstract
Background: Globally there are >200 million major surgical procedures undertaken annually, and about 20% of these involve patients who have coronary artery disease. Many receive nitrous oxide, which impairs methionine synthase, thus inhibiting folate synthesis and increasing postoperative homocysteine levels. Nitrous oxide anesthesia leads to postoperative endothelial dysfunction, and there is some evidence that it increases myocardial ischemia and, possibly, myocardial infarction. We have initiated the Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial to test the hypothesis that in inpatients undergoing anesthesia for major noncardiac surgery, avoidance of nitrous oxide will reduce the incidence of death and major cardiovascular events., Methods: ENIGMA-II is a 7,000-patient, international randomized trial involving patients at risk of coronary artery disease undergoing noncardiac surgery. The patients, health care providers (except for the anesthesiologists), data collectors, and outcome adjudicators are blinded to whether patients receive nitrous oxide-containing or nitrous oxide-free anesthetic. The primary outcome is a composite of death and major nonfatal events (ie, myocardial infarction, cardiac arrest, pulmonary embolism, and stroke) at 30 days after surgery., Results: At present, ENIGMA-II has randomized >1,000 patients in 22 hospitals in 5 countries. To date, patients' mean age is 70 years, 66% are men, 38% have a history of coronary artery disease, 19% have a history of cerebrovascular disease, and 84% have a history of hypertension. Most patients have undergone intra-abdominal 28%, vascular 32%, and orthopedic 16% surgery., Conclusions: The ENIGMA-II Trial will be the largest study yet conducted to ascertain the benefits and risks of removing nitrous oxide from the gas mixture in anesthesia. The results of this large international trial will guide the clinical care of the hundreds of millions of adults undergoing noncardiac surgery annually.
- Published
- 2009
- Full Text
- View/download PDF
42. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
- Author
-
Silbert BS, Evered LA, Scott DA, and Cowie TF
- Subjects
- Aged, Alleles, Apolipoprotein E4 genetics, Cognition Disorders blood, Cognition Disorders etiology, Female, Genotype, Humans, Male, Neuropsychological Tests, Postoperative Complications, Apolipoprotein E4 blood, Cognition Disorders genetics, Coronary Artery Bypass
- Abstract
Background: The plasma protein apolipoprotein E (APOE) is a risk factor for degenerative cognitive decline manifested by mild cognitive impairment and later by Alzheimer's disease. Patients undergoing coronary artery bypass grafting (CABG) are known to have a high prevalence of preexisting cognitive impairment and postoperative cognitive dysfunction. Because both mild cognitive impairment and Alzheimer's disease generally occur in elderly individuals, the age group that commonly present for CABG, we investigated if the APOE epsilon4 allele was associated with patients manifesting preexisting cognitive impairment and postoperative cognitive dysfunction., Methods: The DNA of 282 patients who had undergone neuropsychologic testing before and 3 and 12 months after CABG was analyzed for APOE genotype. Patients were classified as having preexisting cognitive impairment if cognitive function was decreased in two or more tests compared with a healthy control group. Postoperative cognitive dysfunction was defined as a decrease in two or more tests compared with the group mean baseline score., Results: The APOE epsilon4 allele was found in 83 (29.4%) patients. Although preexisting cognitive impairment was present in 105 (37.2%) and postoperative cognitive dysfunction in 33 (12%) and 31 (11%) at 3 and 12 months postoperatively, there was no relationship with the presence of the APOE epsilon4 allele or any of the six genotypes., Conclusions: Preexisting cognitive impairment and postoperative cognitive dysfunction are not associated with APOE epsilon4 genotype, suggesting that cognitive impairment both before and after CABG may not be associated with degenerative cognitive decline.
- Published
- 2008
- Full Text
- View/download PDF
43. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial.
- Author
-
Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, and Pascoe E
- Subjects
- Adolescent, Adult, Anesthesia Recovery Period, Anesthetics, Inhalation administration & dosage, Anesthetics, Inhalation therapeutic use, Female, Folic Acid administration & dosage, Humans, Kaplan-Meier Estimate, Length of Stay statistics & numerical data, Male, Nitrogen administration & dosage, Nitrous Oxide therapeutic use, Odds Ratio, Oxygen administration & dosage, Postoperative Complications chemically induced, Postoperative Nausea and Vomiting chemically induced, Risk, Treatment Outcome, Vitamin B Complex administration & dosage, Anesthetics, Inhalation adverse effects, Nitrous Oxide adverse effects, Surgical Procedures, Operative
- Abstract
Background: Nitrous oxide is widely used in anesthesia, often administered at an inspired concentration around 70%. Although nitrous oxide interferes with vitamin B12, folate metabolism, and deoxyribonucleic acid synthesis and prevents the use of high inspired oxygen concentrations, the consequences of these effects are unclear., Methods: Patients having major surgery expected to last at least 2 h were randomly assigned to nitrous oxide-free (80% oxygen, 20% nitrogen) or nitrous oxide-based (70% N2O, 30% oxygen) anesthesia. Patients and observers were blind to group identity. The primary endpoint was duration of hospital stay. Secondary endpoints included duration of intensive care stay and postoperative complications; the latter included severe nausea and vomiting, and the following major complications: pneumonia, pneumothorax, pulmonary embolism, wound infection, myocardial infarction, venous thromboembolism, stroke, awareness, and death within 30 days of surgery., Results: Of 3,187 eligible patients, 2,050 consenting patients were recruited. Patients in the nitrous oxide-free group had significantly lower rates of major complications (odds ratio, 0.71; 95% confidence interval, 0.56-0.89; P = 0.003) and severe nausea and vomiting (odds ratio, 0.40; 95% confidence interval, 0.31-0.51; P < 0.001), but median duration of hospital stay did not differ substantially between groups (7.0 vs. 7.1 days; P = 0.06). Among patients admitted to the intensive care unit postoperatively, those in the nitrous oxide-free group were more likely to be discharged from the unit on any given day than those in the nitrous oxide group (hazard ratio, 1.35; 95% confidence interval, 1.05-1.73; P = 0.02)., Conclusions: Avoidance of nitrous oxide and the concomitant increase in inspired oxygen concentration decreases the incidence of complications after major surgery, but does not significantly affect the duration of hospital stay. The routine use of nitrous oxide in patients undergoing major surgery should be questioned.
- Published
- 2007
- Full Text
- View/download PDF
44. Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery.
- Author
-
Silbert BS, Scott DA, Evered LA, Lewis MS, and Maruff PT
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Preoperative Care methods, Retrospective Studies, Cognition Disorders diagnosis, Cognition Disorders psychology, Coronary Artery Bypass psychology, Elective Surgical Procedures psychology, Neuropsychological Tests
- Abstract
Background: An accurate assessment of the prevalence of cognitive impairment in patients scheduled for coronary artery bypass graft (CABG) surgery is necessary if valid assumptions regarding cognitive change are to be made. Such an assessment requires the use of a healthy control group free of cardiovascular disease., Methods: In a retrospective observational study, 349 patients scheduled for CABG surgery underwent neuropsychological testing. We compared the results with those from a group of 170 healthy controls without cardiovascular disease and containing more female patients who were matched for age and IQ score. Cognitive impairment was defined as test scores > or =2 sd less than the controls on two or more of the seven tests., Results: The CABG surgery patients performed significantly worse than the control group on all tests except the Grooved Pegboard test (nondominant). When analyzed by group, performance on the verbal learning test was the most impaired. Cognitive impairment was present in 122 (35%) of CABG surgery patients before their procedure. Prior myocardial infarction, age, and IQ were independent predictors of cognitive impairment., Conclusions: Cognitive impairment is prevalent in patients presenting for CABG surgery. Impaired cognition before surgery must be considered when assessing the effects of CABG surgery on cognitive performance.
- Published
- 2007
- Full Text
- View/download PDF
45. The influence of different error estimates in the detection of postoperative cognitive dysfunction using reliable change indices with correction for practice effects.
- Author
-
Lewis MS, Maruff P, Silbert BS, Evered LA, and Scott DA
- Subjects
- Aged, Anesthesia, General methods, Cognition Disorders psychology, Female, Humans, Male, Middle Aged, Postoperative Complications psychology, Prospective Studies, Psychometrics, Reference Values, Reproducibility of Results, Cognition Disorders diagnosis, Coronary Artery Bypass psychology, Neuropsychological Tests statistics & numerical data, Postoperative Complications diagnosis, Practice, Psychological
- Abstract
The reliable change index (RCI) expresses change relative to its associated error, and is useful in the identification of postoperative cognitive dysfunction (POCD). This paper examines four common RCIs that each account for error in different ways. Three rules incorporate a constant correction for practice effects and are contrasted with the standard RCI that had no correction for practice. These rules are applied to 160 patients undergoing coronary artery bypass graft (CABG) surgery who completed neuropsychological assessments preoperatively and 1 week postoperatively using error and reliability data from a comparable healthy nonsurgical control group. The rules all identify POCD in a similar proportion of patients, but the use of the within-subject standard deviation (WSD), expressing the effects of random error, as an error estimate is a theoretically appropriate denominator when a constant error correction, removing the effects of systematic error, is deducted from the numerator in a RCI.
- Published
- 2007
- Full Text
- View/download PDF
46. A prospective observational study of the effect of night duty on the cognitive function of anaesthetic registrars.
- Author
-
Griffiths JD, McCutcheont C, Silbert BS, and Maruff P
- Subjects
- Choice Behavior physiology, Cross-Over Studies, Fatigue psychology, Humans, Learning physiology, Prospective Studies, Psychomotor Performance physiology, Reaction Time physiology, Reproducibility of Results, Anesthesia, Cognition physiology, Personnel Staffing and Scheduling
- Abstract
The issue of fatigue in hospital medical staff represents a potential health and safety risk to both staff and patients, and is receiving worldwide interest. We aimed to characterize the cognitive performance of anaesthetic registrars before and after a series of night shifts. We enrolled nine full-time anaesthetic trainees in an Australian adult tertiary-referral hospital. We conducted a cross-over observational study which tested cognitive performance in participants before and after seven consecutive night shifts and compared this with performance before and after seven consecutive day shifts. Cognitive function was measured using a computerized assessment tool. Participants completed a mean of 62.5% of the requested testing (seven participants completed 87%). There was no significant change in performance before or after any day shift, nor at the commencement of each night shift. There was near perfect accuracy in performance in all tests at all times. There was a statistically significant deterioration in speed of performance for detection and identification tasks at the end of night shift as the week progressed. Anaesthetic registrars demonstrate a significant decline in cognitive performance after a series of night shifts.
- Published
- 2006
- Full Text
- View/download PDF
47. The influence of different error estimates in the detection of post-operative cognitive dysfunction using reliable change indices with correction for practice effects.
- Author
-
Lewis MS, Maruff P, Silbert BS, Evered LA, and Scott DA
- Subjects
- Aged, Cognition Disorders etiology, Female, Humans, Male, Middle Aged, Sensitivity and Specificity, Cognition Disorders physiopathology, Coronary Artery Bypass adverse effects, Data Interpretation, Statistical, Neuropsychological Tests statistics & numerical data, Outcome and Process Assessment, Health Care statistics & numerical data, Practice, Psychological
- Abstract
The reliable change index (RCI) expresses change relative to its associated error, and is useful in the identification of post-operative cognitive dysfunction (POCD). This paper examines four common RCIs that each account for error in different ways. Three rules incorporate a constant correction for practice effects and are contrasted with the standard RCI that had no correction for practice. These rules are applied to 160 patients undergoing coronary artery bypass graft (CABG) surgery who completed neuropsychological assessments preoperatively and 1 week post-operatively using error and reliability data from a comparable healthy non-surgical control group. The rules all identify POCD in a similar proportion of patients, but the use of the within subject standard deviation, expressing the effects of random error, as an error estimate is a theoretically appropriate denominator when a constant error correction, removing the effects of systematic error, is deducted from the numerator in a RCI.
- Published
- 2006
- Full Text
- View/download PDF
48. Detection of postoperative cognitive decline after coronary artery bypass graft surgery is affected by the number of neuropsychological tests in the assessment battery.
- Author
-
Lewis MS, Maruff P, Silbert BS, Evered LA, and Scott DA
- Subjects
- Aged, Cognition Disorders etiology, Cognition Disorders psychology, Elective Surgical Procedures, False Negative Reactions, False Positive Reactions, Female, Follow-Up Studies, Humans, Incidence, Intelligence Tests, Male, Middle Aged, Postoperative Complications etiology, Postoperative Complications psychology, Predictive Value of Tests, Cognition Disorders diagnosis, Coronary Artery Bypass, Neuropsychological Tests, Postoperative Complications diagnosis
- Abstract
Background: The assessment of postoperative cognitive dysfunction after coronary artery bypass graft surgery is made with the repeated administration of cognitive tests. This classification is vulnerable to error, and it has been suggested that increasing the number of tests in a battery while maintaining constant inclusion criteria for postoperative cognitive dysfunction increases the rate of false positive classification of deterioration. The current study tested this by applying a constant rule for cognitive dysfunction using combinations of two to seven cognitive tests., Methods: Two hundred and four coronary artery bypass graft patients (surgical) and 90 healthy nonsurgical controls aged 55 years or older completed a battery of cognitive tests at baseline (preoperative) and 1 week later (postoperative). In both groups, postoperative cognitive dysfunction was classified using all unique combinations of two to seven cognitive tests when performance deteriorated on two or more tests by at least the value of the baseline standard deviation., Results: The average incidence of cognitive dysfunction progressively increased in both groups as the number of cognitive tests increased from two (surgical: 13.3%; control: 3.1%) to seven tests (surgical: 49.4%; control: 41.1%)., Conclusions: Increasing the number of tests used to classify postoperative cognitive dysfunction appears to increase the sensitivity to change in the coronary artery bypass graft group. However, accompanying false positive classifications suggest that this improved sensitivity reflected increased error. Future rules for postoperative cognitive dysfunction need to account for this error and include a control group.
- Published
- 2006
- Full Text
- View/download PDF
49. A comparison of the effect of high- and low-dose fentanyl on the incidence of postoperative cognitive dysfunction after coronary artery bypass surgery in the elderly.
- Author
-
Silbert BS, Scott DA, Evered LA, Lewis MS, Kalpokas M, Maruff P, Myles PS, and Jamrozik K
- Subjects
- Aged, Female, Humans, Length of Stay, Male, Middle Aged, Cognition Disorders etiology, Coronary Artery Bypass adverse effects, Fentanyl administration & dosage, Narcotics administration & dosage, Postoperative Complications etiology
- Abstract
Background: Postoperative cognitive dysfunction (POCD) after coronary artery bypass graft surgery is a common complication for which, despite many clinical investigations, no definitive etiology has been found. The current use of both high- and low-dose fentanyl as anesthetic techniques allowed us to investigate the effect of fentanyl on the incidence of POCD., Methods: Three hundred fifty patients scheduled to undergo elective coronary artery bypass graft surgery were randomized to receive either high-dose fentanyl (50 microg/kg) or low-dose fentanyl (10 mug/kg) as the basis of the anesthetic. All patients underwent neuropsychological testing before surgery and at 1 week, 3 months, and 12 months after surgery., Results: One hundred sixty-eight patients in the low-dose group and 158 patients in the high-dose group were included in the final analysis. Neuropsychological testing was performed on 88%, 93%, and 92% of patients at 1 week, 3 months, and 12 months, respectively. There was no difference between group mean scores at any of the three testing times. Analysis of individual patients by the 20% rule did not detect any differences between groups. The one SD rule, which has fewer false-positive results, detected significantly more patients with POCD in the low-dose group than in the high-dose group at 1 week (23.6% vs. 13.7%; P = 0.03) but not at the other testing times. Patients with POCD spent an average of 1.2 days longer in the hospital than those without POCD (P = 0.021)., Conclusions: High-dose fentanyl is not associated with a difference in the incidence of POCD at 3 or 12 months after surgery. Low-dose fentanyl leads to shorter postoperative ventilation times and may be associated with a greater incidence of POCD 1 week after surgery. Early POCD is associated with an increased duration of stay in the hospital.
- Published
- 2006
- Full Text
- View/download PDF
50. Bilateral vocal cord palsy during carotid endarterectomy under cervical plexus block.
- Author
-
Kwok AO, Silbert BS, Allen KJ, Bray PJ, and Vidovich J
- Subjects
- Aged, Airway Obstruction therapy, Female, Humans, Thyroidectomy adverse effects, Vocal Cord Paralysis diagnosis, Vocal Cord Paralysis therapy, Airway Obstruction etiology, Cervical Plexus, Endarterectomy, Carotid adverse effects, Nerve Block, Vocal Cord Paralysis etiology
- Abstract
We describe a case of vocal cord palsy leading to respiratory obstruction during carotid endarterectomy under cervical plexus block in a patient who had preexisting contralateral vocal cord paralysis subsequent to a previous thyroidectomy. The patient required immediate tracheal intubation and subsequent tracheostomy to maintain the airway postoperatively. Care must be given to avoid contralateral vocal cord paralysis in the presence of a preexisting vocal cord palsy.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.